A novel case of presumed immunotherapy related inflammatory orbitopathy.

Chimeric antigen receptor T-cell (CAR T) therapy is an innovative form of cancer treatment, wherein a patient's own T cells are genetically modified to incorporate chimeric antigen receptors (CARs), enabling them to selectively identify and destroy c…

Preview only. Read the full abstract at the source